These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 30285761)
61. Liver Fibrosis Associated With Crigler-Najjar Syndrome in a Compound Heterozygote: A Case Report. Fata CR; Gillis LA; Pacheco MC Pediatr Dev Pathol; 2017; 20(6):522-525. PubMed ID: 28590786 [TBL] [Abstract][Full Text] [Related]
62. [A case of Crigler-Najjar syndrome of type II]. Mori Y; Kimura H; Suehiro K; Naritomi Y; Maeda Y; Kusaba T; Ishibashi D Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):102-3. PubMed ID: 1902498 [No Abstract] [Full Text] [Related]
63. Crigler-Najjar type II disease inheritance: a family study. Labrune P; Myara A; Hennion C; Gout JP; Trivin F; Odievre M J Inherit Metab Dis; 1989; 12(3):302-6. PubMed ID: 2515370 [TBL] [Abstract][Full Text] [Related]
64. A Novel Pathogenic Elfar W; Järvinen E; Ji W; Mosorin J; Sega AG; Iuga AC; Lobritto SJ; Konstantino M; Chan A; Finel M; Lakhani SA Drug Metab Dispos; 2019 Jan; 47(1):45-48. PubMed ID: 30385458 [TBL] [Abstract][Full Text] [Related]
65. Mutation of UGT1A1 gene in a case of Crigler-Najjar syndrome type II. Ishihara T; Sato H; Fukui S; Kagawa K; Kaito M; Gabazza EC; Adachi Y Am J Gastroenterol; 1999 Jun; 94(6):1711-2. PubMed ID: 10364060 [No Abstract] [Full Text] [Related]
66. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206 [TBL] [Abstract][Full Text] [Related]
68. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Bosma PJ; Chowdhury NR; Goldhoorn BG; Hofker MH; Oude Elferink RP; Jansen PL; Chowdhury JR Hepatology; 1992 May; 15(5):941-7. PubMed ID: 1568736 [TBL] [Abstract][Full Text] [Related]
69. Crigler-Najjar Syndrome: Current Perspectives and the Application of Clinical Genetics. Ebrahimi A; Rahim F Endocr Metab Immune Disord Drug Targets; 2018; 18(3):201-211. PubMed ID: 29237388 [TBL] [Abstract][Full Text] [Related]
71. Update on a previously reported missense mutation: The c.1160 C>A mutation in the UGT1A1 gene result in Crigler-Najjar syndrome type 1. Ghorbani MJ; Dehghani SM Mol Genet Genomic Med; 2021 Nov; 9(11):e1805. PubMed ID: 34545702 [No Abstract] [Full Text] [Related]
72. [The analysis of UGT1A1 gene mutations in hereditary unconjugated hyperbilirubinemia]. Sun L; Zhang L; Li M; Teng XY; Qi LM; Zhou XG; Lang ZW; Wang P Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):863-866. PubMed ID: 27978934 [No Abstract] [Full Text] [Related]
73. UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation. Mohammadi Asl J; Tabatabaiefar MA; Galehdari H; Riahi K; Masbi MH; Zargar Shoshtari Z; Rahim F Biomed Res Int; 2013; 2013():342371. PubMed ID: 24286076 [TBL] [Abstract][Full Text] [Related]
74. A homozygous mutation in UGT1A1 exon 5 may be responsible for persistent hyperbilirubinemia in a Japanese girl with Gilbert's syndrome. Nakagawa T; Mure T; Yusoff S; Ono E; Kusuma Harahap IS; Morikawa S; Morioka I; Takeshima Y; Nishio H; Matsuo M Kobe J Med Sci; 2011 Jul; 57(1):E26-31. PubMed ID: 22169899 [TBL] [Abstract][Full Text] [Related]
75. Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene. Kraemer D; Klinker H J Hepatol; 2002 May; 36(5):706-7. PubMed ID: 11983459 [No Abstract] [Full Text] [Related]
76. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Strassburg CP Drug Metab Rev; 2010 Feb; 42(1):168-81. PubMed ID: 20070246 [TBL] [Abstract][Full Text] [Related]
77. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome. Aronson SJ; Veron P; Collaud F; Hubert A; Delahais V; Honnet G; de Knegt RJ; Junge N; Baumann U; Di Giorgio A; D'Antiga L; Ginocchio VM; Brunetti-Pierri N; Labrune P; Beuers U; Bosma PJ; Mingozzi F Hum Gene Ther; 2019 Oct; 30(10):1297-1305. PubMed ID: 31502485 [TBL] [Abstract][Full Text] [Related]
78. [Inherited disorders of bilirubin metabolism]. Rossi F; Francese M; Iodice RM; Falcone E; Vetrella S; Punzo F; De Vita S; Perrotta S Minerva Pediatr; 2005 Apr; 57(2):53-63. PubMed ID: 15985997 [TBL] [Abstract][Full Text] [Related]
79. A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Bosma PJ; Goldhoorn B; Oude Elferink RP; Sinaasappel M; Oostra BA; Jansen PL Gastroenterology; 1993 Jul; 105(1):216-20. PubMed ID: 8514037 [TBL] [Abstract][Full Text] [Related]
80. Crigler-Najjar syndrome type 2. Huang CS; Tan N; Yang SS; Sung YC; Huang MJ J Formos Med Assoc; 2006 Nov; 105(11):950-3. PubMed ID: 17098698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]